Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Molecular Endocrinology (Baltimore, Md.)|October 9, 2009
Genomic and nongenomic cross talk between the gonadotropin-releasing hormone receptor and glucocorticoid receptor signaling pathwaysAndrea Kotitschke, Hanél Sadie-Van Gijsen, Chanel Avenant, et al.
Steroids|March 10, 2022
Differential off-target glucocorticoid activity of progestins used in endocrine therapyMaleshigo Komane, Chanel Avenant, Renate Louw-du Toit, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|October 27, 2022
Increased HIV-1 infection in PBMCs treated in vitro with menstrual cycle phase hormones or medroxyprogesterone acetate likely occurs via different mechanismsAlexis J Bick, Chanel Avenant, Michele Tomasicchio, et al.
Biochemical and Biophysical Research Communications|October 3, 2020
Characterisation of progestins used in hormonal contraception and progesterone via the progesterone receptorKim Enfield, Meghan Cartwright, Renate Louw-du Toit, et al.
Molecular and Cellular Endocrinology|November 15, 2008
Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interactionKatharina Ronacher, Katie Hadley, Chanel Avenant, et al.
Plos One|May 21, 2014
The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptorYashini Govender, Chanel Avenant, Nicolette J D Verhoog, et al.
Scientific Reports|March 15, 2019
The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrationsRoslyn M Ray, Michelle F Maritz, Chanel Avenant, et al.
Plos One|April 27, 2018
Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levelsMichelle F Maritz, Roslyn M Ray, Alexis J Bick, et al.
Plos One|March 26, 2024
Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trialMandisa Singata-Madliki, Jenni Smit, Mags Beksinska, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 11, 2025
Injectable Contraceptives Differentially Affect Select CD4+ HIV-1 Target Cells in the Genital Tract but Not Systemically: Implications for HIV-1 AcquisitionChanel Avenant, Alexis J Bick, Johnson M Moliki, et al.
Pageof 3